ACCESS Newswire
29 Sep 2022, 16:26 GMT+10
TORONTO, ON / ACCESSWIRE / September 29, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (OTCQB:NGMDF) ('NuGen'' or the 'Company'), a leader in needle-free drug delivery, is pleased to announce that it intends to file for a new patent in the United States, Europe and China.
The patent would protect the refill design mechanism for NuGen's needle-free injection device which allows for the insertion of the medicine vial directly into the device. This technology was patented in the Netherlands under patent ID 2025322 in October 2021 and at such time, the Global Protection under the PCT route was acquired. NuGen will now file for national patent protection for the above-mentioned territories. These territories are important markets for insulin therapy and offer the biggest opportunities for NuGen. The patent protects a technology that allows for the filling of the needle-free syringe (nozzle) directly from the vial that is stored inside the device, greatly enhancing both safety and usability of insulin or other pharmaceutical injections.
'These international patent applications represent the next logical step for our needle-free injection devices as we continue to improve on our innovative technology,' said Michael Wright, CEO of NuGen. By including the vial inside the injector, we will reduce the steps required to perform an injection and provide easier useability for the chronic patients that require multiple injections per day.
NuGen was awarded a patent for the refill mechanism and its needle-free syringe cartridge adapter combination design in The Netherlands in October 2021.
About NuGen Medical Devices
NuGen is an emerging specialty medical device company developing the next generation of needle-free technologies and other innovative medical delivery products. The company's products, which include the InsuJet™ and PetJet™ needle-free injection systems, are designed to improve the lives of millions of people and animals. NuGen continues to receive approval in numerous countries, including Canada. NuGen's products are designed for use in several important fields including, but not limited to, diabetes, veterinary medicine, and vaccines.
For More Information visit: www.nugenmd.com
Twitter: @NuGenMD
LinkedIn: https://www.linkedin.com/company/nugenmd/
For further information, please contact:
Michael Wright
President and CEO
NuGen Medical Devices Inc.
[email protected]
(833) 285-2666
Investor Relations Contact:
Kin Communications Inc.
[email protected]
(604) 684-6730
Twitter: @KinComm
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this press release include the Company's 2022 objectives of securing additional distribution and sales agreements, making submissions for regulatory approvals and capitalizing on additional market opportunities. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.
SOURCE: NuGen Medical Devices
Get a daily dose of Vancouver Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Vancouver Star.
More InformationWASHINGTON, D.C.: According to a report in the Wall Street Journal, former President Donald Trump is planning to sign an order to shut...
Already under siege, the heavily-blockaded Gaza Strip, housing more than two million displaced people, as well as the remaining Israeli...
WASHINGTON, D.C.: U.S. Secretary of State Marco Rubio has announced new visa restrictions. The policy will apply to foreign government...
LOS ANGELES, California: Former Los Angeles Fire Chief Kristin Crowley lost her bid to get her job back after being fired by Mayor...
Last Sunday, the Israeli-Palestinian co-production No Other Land was awarded an Academy Award for best documentary. The Oscar – a first...
WASHINGTON, D.C.: The Supreme Court is to hear arguments in a case that could determine the future of nuclear waste storage in the...
LONDON, U.K.: British Petroleum CEO Murray Auchincloss saw his pay package drop to 5.4 million pounds (US$6.95 million) in 2024, down...
BONN, Germany: DHL plans to cut 8,000 jobs in Germany this year, marking its most significant domestic workforce reduction in at least...
BEIJING, China: China has set an economic growth target of around five percent for 2025, signaling efforts to stabilize the economy...
WASHINGTON, D.C.: Elon Musk's company SpaceX said this week that its Starlink satellite unit is not trying to take over any Federal...
SACRAMENTO, California: Starting July 1, California state employees will be required to work in person at least four days a week under...
FRANKFURT, Germany: Germany is set to loosen its strict debt limits in a historic shift that could unlock over 1 trillion euros ($1.08...